세계의 AI 활용 신경 재활 외골격 시장 보고서(2025년)

An AI-enhanced neurorehabilitation exoskeleton is a wearable robotic system designed to support and optimize motor recovery through intelligent, adaptive control. By leveraging advanced AI algorithms, the system continuously analyzes the user's movement patterns to provide personalized and precise assistance during therapy sessions. Through real-time feedback and dynamic adjustments, it facilitates efficient rehabilitation by improving coordination, muscle strength, and overall functional mobility over time.

The key components of artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons include hardware, software, and services. Hardware encompasses the physical elements of the exoskeleton that enable safe, effective, and user-responsive assisted movement. These devices can be classified based on mobility type as either mobile or stationary and integrate various technologies, such as powered, passive, or hybrid systems. They are applied across multiple therapeutic domains, including stroke rehabilitation, spinal cord injury, traumatic brain injury, and multiple sclerosis. The main end-users of these exoskeletons include hospitals and clinics, rehabilitation centers, and home care settings, where they enhance recovery outcomes and promote patient independence.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market statistics, including artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market share, artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry. This artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth during the historic period can be attributed to the growing adoption of rehabilitation robotics, the rising need for enhanced patient mobility, the expansion of collaborations between technology and healthcare companies, the improvement in medical device interoperability, and the increasing demand for minimally invasive rehabilitation solutions.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth during the forecast period can be attributed to increased investment in medical robotics, greater customization of exoskeleton devices to meet diverse patient needs, the adoption of interdisciplinary approaches in rehabilitation therapies, growing demand for mobility solutions in developing regions, and a rise in patient preference for non-invasive treatment options. Key trends in the forecast period include progress in AI-driven exoskeleton control, integration of advanced sensors for precise movement, innovation in lightweight exoskeleton design, incorporation of cloud-based rehabilitation data, and advancements in personalized therapy algorithms.

The rising incidence of neurological disorders is expected to drive the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to impairments in movement, cognition, sensation, or other bodily functions. The global increase in neurological disorders is largely attributed to an aging population, as older adults are more susceptible to conditions such as stroke, dementia, and Parkinson's disease, which tend to become more prevalent with age. Artificial intelligence (AI) enhanced neurorehabilitation exoskeletons assist individuals with neurological disorders by providing personalized, adaptive therapy that improves motor function, accelerates recovery, and compensates for movement impairments through real-time monitoring and intelligent adjustments to each patient's specific needs. For example, in March 2023, according to the Alzheimer's Association, a US-based nonprofit health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Hence, the increasing incidence of neurological disorders is fueling the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market.

Major players in the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market are emphasizing the integration of innovative technologies such as robotic control systems to enhance mobility, stability, and rehabilitation outcomes. Robotic control systems are technologies that coordinate and manage the movements of a robot or exoskeleton, helping users walk, stand, and perform daily activities safely and efficiently by enabling precise, stable, and adaptive motion. For instance, in May 2025, Wandercraft SAS, a France-based robotics company, initiated clinical trials in the United States for its AI-powered personal exoskeleton. The device integrates advanced physical AI and robotic control systems to assist individuals with spinal cord injuries, stroke, and other mobility impairments in standing, walking, and navigating various surfaces safely. Continuously adapting to user movements in real time, it improves mobility, stability, and rehabilitation outcomes. Equipped with a joystick-based control system and intelligent algorithms that anticipate changes in weight, surface, and speed, the exoskeleton promotes greater independence while minimizing secondary health risks associated with long-term wheelchair use.

In July 2025, Moody Neurorehabilitation Institute Inc., a US-based healthcare organization, acquired Wandercraft SAS's Atalante X exoskeleton for an undisclosed amount. Through this acquisition, Moody Neurorehabilitation Institute Inc. aims to strengthen its rehabilitation capabilities by offering high-intensity, hands-free gait therapy, improving outcomes for patients with complex mobility challenges, including those recovering from traumatic brain injuries. Wandercraft SAS is a France-based medical robotics company that specializes in providing AI enhanced neurorehabilitation exoskeletons.

Major players in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., and MediTouch Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2024. The regions covered in artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market consists of revenues earned by entities by providing services such as patient assessment services, therapy planning services, remote monitoring services, maintenance and support services, and rehabilitation consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market also includes sales of brain-computer interface (BCI)-controlled exoskeletons, occupational exoskeletons for healthcare workers, AI-integrated exoskeletons with advanced sensors, and modular and customizable exoskeleton systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Mobility Type: Mobile; Stationary
• 3) By Technology: Powered; Passive; Hybrid
• 4) By Application: Stroke Rehabilitation; Spinal Cord Injury; Traumatic Brain Injury; Multiple Sclerosis
• 5) By End-User: Hospitals And Clinics; Rehabilitation Centers; Home Care Settings
• Subsegments:
• 1) By Hardware: Exoskeleton Frames; Actuators And Motors; Sensors And Wearable Devices; Control Units And Embedded Electronics
• 2) By Software: Motion Planning Software; Rehabilitation Protocol Software; Data Analytics And Monitoring Software; Connectivity And Integration Software
• 3) By Services: Implementation And Setup Services; Training And Education Services; Maintenance And Support Services; Remote Monitoring And Assistance Services
• Companies Mentioned: Ottobock SE & Co. KGaA; Shanghai Fourier Intelligence Co. Ltd.; Kinova Inc.; Cyberdyne Inc.; Hocoma AG; Myomo Inc.; Neofect Co. Ltd.; Ekso Bionics Holdings Inc.; ReWalk Robotics Ltd.; AlterG Inc.; RENU ROBOTICS CORPORATION; ExoAtlet Global S.A.; REEV Robotics; Bionik Laboratories Corp.; Rex Bionics PLC; Wearable Robotics Srl; Gogoa Mobility Robots S.L.; Technaid S.L.; Bionic Yantra Pvt. Ltd.; MediTouch Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Segmentation

• 6.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile
• Stationary
• 6.3. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powered
• Passive
• Hybrid
• 6.4. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stroke Rehabilitation
• Spinal Cord Injury
• Traumatic Brain Injury
• Multiple Sclerosis
• 6.5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Rehabilitation Centers
• Home Care Settings
• 6.6. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exoskeleton Frames
• Actuators And Motors
• Sensors And Wearable Devices
• Control Units And Embedded Electronics
• 6.7. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Motion Planning Software
• Rehabilitation Protocol Software
• Data Analytics And Monitoring Software
• Connectivity And Integration Software
• 6.8. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implementation And Setup Services
• Training And Education Services
• Maintenance And Support Services
• Remote Monitoring And Assistance Services

7. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 8.1. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 9.1. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 9.2. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 10.1. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 11.1. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 11.2. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 12.1. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 13.1. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 14.1. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 14.2. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 15.1. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 15.2. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 16.1. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 17.1. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 18.1. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 19.1. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 20.1. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 21.1. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 22.1. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 23.1. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 23.2. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 24.1. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 24.2. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 25.1. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 25.2. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 26.1. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 26.2. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 27.1. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 28.1. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 28.2. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

• 29.1. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
• 29.2. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape
• 30.2. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Company Profiles
  • 30.2.1. Ottobock SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Shanghai Fourier Intelligence Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Kinova Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cyberdyne Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hocoma AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Other Major And Innovative Companies

• 31.1. Myomo Inc.
• 31.2. Neofect Co. Ltd.
• 31.3. Ekso Bionics Holdings Inc.
• 31.4. ReWalk Robotics Ltd.
• 31.5. AlterG Inc.
• 31.6. RENU ROBOTICS CORPORATION
• 31.7. ExoAtlet Global S.A.
• 31.8. REEV Robotics
• 31.9. Bionik Laboratories Corp.
• 31.10. Rex Bionics PLC
• 31.11. Wearable Robotics Srl
• 31.12. Gogoa Mobility Robots S.L.
• 31.13. Technaid S.L.
• 31.14. Bionic Yantra Pvt. Ltd.
• 31.15. MediTouch Inc.

32. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

35. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer